Fig. 3From: Defining a therapeutic range for adalimumab serum concentrations in the management of pediatric noninfectious uveitis, a step towards personalized treatmentReceiver-Operator Characteristics Analyses. The adalimumab cut-off value corresponding with the most optimal trade-off between sensitivity and specificity is 9.6 µg/mL (arrowhead)Back to article page